News Release
  September 16, 2013

CONTACT:

Karen Kreeger

215-349-5658
karen.kreeger@uphs.upenn.edu

Perelman School of Medicine


This invitation to cover is available online at
http://www.uphs.upenn.edu/news/News_Releases/2013/09/itmat/

Lab-on-a-chip tech, brain mapping and microbiome highlighted at translational med meeting

Penn's Institute for Translational Medicine and Therapeutics' 8th Annual International Symposium, Harnessing the Paradox: Personalization and the Science of Scale

PHILADELPHIA — The Institute for Translational Medicine and Therapeutics' 8th Annual International Symposium (ITMAT) symposium, Harnessing the Paradox: Personalization and the Science of Scale, to be held in October 2013, will address topics of direct relevance to translational science. ITMAT is part of the Perelman School of Medicine at the University of Pennsylvania.

Speakers will include those dealing with large infrastructural investments, such as the recently funded $1 billion European brain mapping program, as well as such broad areas of scientific advancement as systems biology, optogenetics and lab-on-a-chip technologies and specific advances in metabolism, metabolomics and the microbiome.

Garret A. FitzGerald, Director of ITMAT, will be hosting the event. The speakers and talks include:

  • Leroy Hood, MD, PhD, President, Institute for Systems Biology Systems Medicine, Transformational Technologies and the Emergence of Proactive P4 Medicine (Predictive, Preventive, Personalized and Participatory)
  • Sir Rory Collins, FMed Sci, FRCP, Professor of Medicine and Epidemiology, Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford UK Biobank: An Open Access Resource for Health Research
  • Frederic Bushman, PhD, Professor of Microbiology, Perelman School of Medicine at the University of Pennsylvania The Human Microbiome in Health and Disease
  • Jayne Danska, PhD, Senior Scientist, Program in Genetics and Genome Biology, the Hospital for Sick Children, Professor, Department of Immunology and Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Canada The Architecture of Complex Disease: Genes, Sex, Bugs and Diabetes
  • Chi Van Dang, MD, PhD, Director, Abramson Cancer Center, John H. Glick, MD Abramson Cancer Center Director's Professor, Perelman School of Medicine at the University of Pennsylvania Targeting Cancer Metabolism
  • Shoukhrat Mitalipov, PhD, Oregon National Primate Research Center, Oregon Health & Science University Reproductive and Reprogramming Approaches for Treatment of mtDNA Disease
  • Richard Frackowiak, MA, MD, DSc, Professor, Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland The Human Brain Project: from Phenomena to Biology

The dinner speaker will be Chris Austin, MD, Director of National Center for Advancing Translational Sciences.

Date: Monday and Tuesday, October 14-15, 2013

Location: Smilow Center for Translational Research Rubenstein Auditorium and Lobby, 3400 Civic Center Blvd, Philadelphia, PA 19104

What: 2013 Full Agenda

Registration is open and is required for attendance and for participation via web. Please register at one of the following links:

  • Follow this link to attend the 2013 ITMAT Symposium
  • Follow this link to participate via web in the 2013 ITMAT Symposium

Funding for this conference was made possible in part by R13TR000047-04 from the National Center for Advancing Translational Sciences.

 

###

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.